Difficulty: Medium
Average Score: 74%
Practice
Increased fecal calprotectin concentration is seen in
Correct answer
C
Rationale
In pediatric gastrointestinal disorders, increased fecal calprotectin concentration is seen in intestinal inflammation, making option C the correct answer. Calprotectin is a protein released by neutrophils in response to inflammation in the intestines. Elevated levels of fecal calprotectin indicate ongoing inflammation in the gastrointestinal tract, making it a valuable marker for conditions like inflammatory bowel disease (IBD) and other inflammatory conditions.
Option A, fat malabsorption, is incorrect because it does not directly lead to an increase in fecal calprotectin levels. In fat malabsorption, the primary concern is the incomplete absorption of dietary fats, leading to symptoms like steatorrhea. Carbohydrate malabsorption, option B, similarly does not directly affect fecal calprotectin levels.
Option D, pancreatic function reduction, is also incorrect in the context of fecal calprotectin concentration. Impaired pancreatic function typically leads to issues with digestion and absorption of nutrients, particularly fats and proteins, but it does not directly impact fecal calprotectin levels, which are more specific to intestinal inflammation.
Educationally, understanding the significance of fecal calprotectin levels in pediatric gastrointestinal disorders is crucial for healthcare professionals working with children. It helps in diagnosing and monitoring conditions like IBD, allowing for timely intervention and management. By grasping the relationship between inflammation and fecal calprotectin levels, healthcare providers can make informed decisions regarding treatment strategies and patient care.
Option A, fat malabsorption, is incorrect because it does not directly lead to an increase in fecal calprotectin levels. In fat malabsorption, the primary concern is the incomplete absorption of dietary fats, leading to symptoms like steatorrhea. Carbohydrate malabsorption, option B, similarly does not directly affect fecal calprotectin levels.
Option D, pancreatic function reduction, is also incorrect in the context of fecal calprotectin concentration. Impaired pancreatic function typically leads to issues with digestion and absorption of nutrients, particularly fats and proteins, but it does not directly impact fecal calprotectin levels, which are more specific to intestinal inflammation.
Educationally, understanding the significance of fecal calprotectin levels in pediatric gastrointestinal disorders is crucial for healthcare professionals working with children. It helps in diagnosing and monitoring conditions like IBD, allowing for timely intervention and management. By grasping the relationship between inflammation and fecal calprotectin levels, healthcare providers can make informed decisions regarding treatment strategies and patient care.